Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for pseudoephedrine
Perform Another (Advanced) Search
Related Words: pseudoephedrine
5 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. Newly Approved Drug Therapies (159) Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate), Schering-Plough, ...Drug Therapies (159) Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate), Schering-Plough, Drug Information The following information is obtained from various newswires, published medical ......presentations. Drug Name: Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate) Company: Schering-Plough Approval Status: Approved August 1996 Treatment Area: nasal congestion General Information ...View Page
2. Newly Approved Drug Therapies (635) Children's Motrin Cold, McNeil Consumer Products, ...and pains, fever, headache, and sore throat. This product's active ingredients are ibuprofen and pseudoephedrine HCl, and it will be available for over-the-counter purchase. Children's Motrin is ......inflammatory (NSAIDs) class of drugs, and acts by reducing levels of prostaglandins in the body. Pseudoephedrine acts as a decongestant, and is classified as an indirect sympathomimetic amine. Additional Information For ...View Page
3. Newly Approved Drug Therapies (694) Tavist (clemastine fumarate), Novartis, ...Tavist Allergy/Sinus/Headache contains the analgesic acetaminophen, the antihistamine clemastine fumarate, and the decongestant pseudoephedrine hydrochloride. Additional Information For additional information on Tavist Allergy/Sinus/Headache, please visit Novartis Consumer ...View Page
4. CenterWatch: Pulmonary/Respiratory Diseases Approved Drug Therapies ...Approved October 1996 Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate) ; Schering-Plough; Treatment for nasal congestion, Approved August 1996 Covera-HS (verapamil) ; G.D ...View Page
5. CenterWatch: List of Newly Approved Drug Thearapies ...Approved October 1996 Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate) ; Schering-Plough; Treatment for nasal congestion, Approved August 1996 Covera-HS (verapamil) ; G.D ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.